|
EP1855694B1
(en)
|
2005-02-09 |
2020-12-02 |
Sarepta Therapeutics, Inc. |
Antisense composition for treating muscle atrophy
|
|
US8236557B2
(en)
*
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
ES2634118T3
(es)
|
2009-02-11 |
2017-09-26 |
The University Of North Carolina At Chapel Hill |
Vectores de virus modificados y métodos para fabricar y utilizar los mismos
|
|
WO2011088081A1
(en)
|
2010-01-12 |
2011-07-21 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
EP2531604B1
(en)
*
|
2010-02-05 |
2017-04-05 |
The University of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
US9409953B2
(en)
|
2011-02-10 |
2016-08-09 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
CN103405774A
(zh)
*
|
2012-10-24 |
2013-11-27 |
尹海芳 |
一种新型药物靶向运输辅助剂
|
|
US20140140969A1
(en)
*
|
2012-11-20 |
2014-05-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for muscular dystrophies
|
|
US9624282B2
(en)
|
2012-11-26 |
2017-04-18 |
The Curators Of The University Of Missouri |
Microdystrophin peptides and methods for treating muscular dystrophy using the same
|
|
WO2014144229A1
(en)
|
2013-03-15 |
2014-09-18 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav vectors
|
|
US9447433B2
(en)
|
2013-03-15 |
2016-09-20 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
EP3245220B1
(en)
|
2015-01-14 |
2023-09-20 |
The University of North Carolina at Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
EP4599851A2
(en)
|
2015-01-16 |
2025-08-13 |
University of Washington |
Novel micro-dystrophins and related methods of use
|
|
HK1248554A1
(zh)
|
2015-02-20 |
2018-10-19 |
Board Of Regents, The University Of Texas System |
作为疫苗和载体的减毒衣原体的方法和组合物
|
|
GB201507842D0
(en)
*
|
2015-05-07 |
2015-06-17 |
New Royal Holloway & Bedford |
Production of large-sized microdystrophins in an AAV-based vector configuration
|
|
CA2996420A1
(en)
|
2015-09-28 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for antibody-evading virus vectors
|
|
EA201890908A1
(ru)
|
2015-10-09 |
2018-10-31 |
Сарепта Терапьютикс, Инк. |
Композиции и способы для лечения мышечной дистрофии дюшенна и сходных нарушений
|
|
EP3377042A4
(en)
|
2015-11-16 |
2019-05-29 |
The Research Institute at Nationwide Children's Hospital |
MATERIALS AND METHOD FOR THE TREATMENT OF TITIN-BASED MYOPATHIES AND OTHER TITINOPATHIES
|
|
CA3008013A1
(en)
|
2015-12-14 |
2017-06-22 |
The University Of North Carolina At Chapel Hill |
Modified capsid proteins for enhanced delivery of parvovirus vectors
|
|
MX391208B
(es)
|
2016-04-15 |
2025-03-21 |
Res Inst Nationwide Childrens Hospital |
Vectores del virus adenoasociado de b-sarcoglicano y microarn-29 y el uso de los mismos en la distrofia muscular.
|
|
MA45477A
(fr)
*
|
2016-04-15 |
2019-02-20 |
Res Inst Nationwide Childrens Hospital |
Administration à vecteurs de virus adéno-associé de microarn-29 et micro-dystrophine pour traiter la dystrophie musculaire
|
|
EP4011206B1
(en)
|
2016-06-21 |
2023-11-01 |
The Curators of the University of Missouri |
Modified dystrophin proteins
|
|
CA2971303A1
(en)
|
2016-06-21 |
2017-12-21 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
|
EP3491008A2
(en)
|
2016-07-26 |
2019-06-05 |
BioMarin Pharmaceutical Inc. |
Novel adeno-associated virus capsid proteins
|
|
JP7165410B2
(ja)
|
2016-08-19 |
2022-11-04 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド |
組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物
|
|
CA3046347A1
(en)
|
2016-12-07 |
2018-06-14 |
University Of Florida Research Foundation, Incorporated |
Il-1ra cdnas
|
|
US11541131B2
(en)
|
2017-03-10 |
2023-01-03 |
Genethon |
Treatment of glycogen storage disease III
|
|
ES2966692T3
(es)
|
2017-03-15 |
2024-04-23 |
Univ North Carolina Chapel Hill |
Vectores de virus adenoasociados poliploides y métodos de fabricación y uso de los mismos
|
|
US11338045B2
(en)
|
2017-03-17 |
2022-05-24 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
EP3635100A4
(en)
|
2017-05-05 |
2021-03-24 |
University of Florida Research Foundation, Incorporated |
COMPOSITIONS AND METHOD OF EXPRESSION OF OTOFERLIN
|
|
EP3697915A4
(en)
|
2017-10-18 |
2021-12-08 |
Research Institute at Nationwide Children's Hospital |
ADENO-ASSOCIATED VIRUS VECTOR ADMINISTRATION SPECIFIC TO MUSCLES TO TREAT MUSCLE DYSTROPHY
|
|
IL275880B2
(en)
|
2018-01-31 |
2025-10-01 |
Res Inst Nationwide Childrens Hospital |
Gene therapy for brachioradial muscular dystrophy type 2C
|
|
WO2019169132A1
(en)
|
2018-02-28 |
2019-09-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for antibody-evading virus vectors
|
|
CN112272672A
(zh)
|
2018-04-03 |
2021-01-26 |
斯特里迪比奥公司 |
抗体逃避性病毒载体
|
|
SG11202009451VA
(en)
|
2018-04-03 |
2020-10-29 |
Stridebio Inc |
Antibody-evading virus vectors
|
|
CA3094465A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Virus vectors for targeting ophthalmic tissues
|
|
CN112601454B
(zh)
|
2018-04-16 |
2023-10-27 |
宾夕法尼亚州大学信托人 |
用于治疗杜兴肌营养不良的组合物和方法
|
|
CA3098198A1
(en)
|
2018-04-27 |
2019-10-31 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
EP3790627A2
(en)
|
2018-05-09 |
2021-03-17 |
BioMarin Pharmaceutical Inc. |
Methods of treating phenylketonuria
|
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
|
US10758629B2
(en)
|
2018-05-29 |
2020-09-01 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
US12491265B2
(en)
*
|
2018-06-18 |
2025-12-09 |
Research Institute At Nationwide Children's Hospital |
Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy
|
|
CA3104113A1
(en)
|
2018-06-22 |
2019-12-26 |
Asklepios Biopharmaceutical, Inc. |
Vectors for gene delivery that persist within cells
|
|
SG11202012715UA
(en)
|
2018-06-29 |
2021-01-28 |
Res Inst Nationwide Childrens Hospital |
Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a
|
|
US12188041B2
(en)
|
2018-11-01 |
2025-01-07 |
University Of Florida Research Foundation, Incorporated |
Codon optimized otoferlin AAV dual vector gene therapy
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
CN119307494A
(zh)
|
2019-02-08 |
2025-01-14 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
JP2022521776A
(ja)
|
2019-02-26 |
2022-04-12 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Β－サルコグリカンのアデノ随伴ウイルスベクター送達および筋ジストロフィーの治療
|
|
SG11202110146VA
(en)
|
2019-03-21 |
2021-10-28 |
Stridebio Inc |
Recombinant adeno-associated virus vectors
|
|
CA3130196A1
(en)
*
|
2019-03-25 |
2020-10-01 |
Isabelle Richard |
Production of large-sized quasidystrophins using overlapping aav vectors
|
|
JP2022529662A
(ja)
|
2019-04-26 |
2022-06-23 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
二重グリカン結合ａａｖ２．５ベクターのための方法および組成物
|
|
EP3976806A1
(en)
|
2019-05-30 |
2022-04-06 |
Solidus Biosciences, Inc. |
Recombinant herpesvirales vector
|
|
JP2022540819A
(ja)
*
|
2019-07-10 |
2022-09-20 |
ユニバーシティ オブ ワシントン |
非ウイルス性免疫標的化
|
|
MY210230A
(en)
|
2019-08-21 |
2025-09-04 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector delivery of alpha-sarcoglycan and the treatment of muscular dystrophy
|
|
EP4045525A1
(en)
|
2019-10-17 |
2022-08-24 |
Stridebio, Inc. |
Adeno-associated viral vectors for treatment of niemann-pick disease type c
|
|
EP4054618A1
(en)
|
2019-11-06 |
2022-09-14 |
Association Institut de Myologie |
Combined therapy for muscular diseases
|
|
BR112022009895A2
(pt)
*
|
2019-11-28 |
2022-08-09 |
Regenxbio Inc |
Construtos de terapia de gene de microdistrofina e usos dos mesmos
|
|
CA3174500A1
(en)
|
2020-04-01 |
2021-10-07 |
University Of Florida Research Foundation, Incorporated |
Dual aav-myo7a vectors with improved safety for the treatment of ush1b
|
|
CN115485291A
(zh)
|
2020-04-29 |
2022-12-16 |
百时美施贵宝公司 |
具血影蛋白融合结构域的微型化抗肌萎缩蛋白及其用途
|
|
TW202227632A
(zh)
|
2020-08-19 |
2022-07-16 |
美商史崔德生物公司 |
用於治療雷特症候群之腺相關病毒載體
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
ES3001131T3
(es)
|
2020-10-28 |
2025-03-04 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para la unión dual de glicanos al vector de AAV2.5
|
|
WO2022093769A1
(en)
|
2020-10-28 |
2022-05-05 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向ｔ細胞之ａａｖ載體
|
|
CA3218333A1
(en)
|
2021-04-05 |
2022-10-13 |
Solid Biosciences Inc. |
Recombinant herpesvirales vector
|
|
JP2024515626A
(ja)
|
2021-04-16 |
2024-04-10 |
アスクレピオス バイオファーマシューティカル， インコーポレイテッド |
血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン
|
|
TW202309293A
(zh)
*
|
2021-04-26 |
2023-03-01 |
美商銳進科斯生物股份有限公司 |
用於治療肌縮蛋白症(dystrophinopathy)之微小肌縮蛋白基因療法給藥
|
|
US20240390522A1
(en)
*
|
2021-09-28 |
2024-11-28 |
University Of Florida Research Foundation, Incorporated |
Gene therapy for duchenne muscular dystrophy
|
|
WO2023060269A1
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
CN115960946A
(zh)
*
|
2021-10-09 |
2023-04-14 |
中国科学院分子植物科学卓越创新中心 |
调节植物镁离子吸收和转运的方法
|
|
EP4219726A1
(en)
|
2021-10-15 |
2023-08-02 |
Research Institute at Nationwide Children's Hospital |
Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy
|
|
CA3248878A1
(en)
*
|
2022-01-17 |
2023-07-20 |
Dinaqor Ag |
GENE THERAPY COMPOSITION AND TREATMENT OF DYSTROPHIN-RELATED CARDIOMYOPATHY
|
|
EP4215614A1
(en)
|
2022-01-24 |
2023-07-26 |
Dynacure |
Combination therapy for dystrophin-related diseases
|
|
WO2023150687A1
(en)
|
2022-02-04 |
2023-08-10 |
Ginkgo Bioworks, Inc. |
Recombinant adeno-associated virus vectors, and methods of use thereof
|
|
US20250288641A1
(en)
*
|
2022-04-27 |
2025-09-18 |
The Curators Of The University Of Missouri |
Micro-dystrophin for heart protection
|
|
WO2024124019A2
(en)
|
2022-12-07 |
2024-06-13 |
Ginkgo Bioworks, Inc. |
Aav vectors targeting hematopoietic stem cells
|
|
WO2024216244A2
(en)
|
2023-04-13 |
2024-10-17 |
Regenxbio Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2025017168A1
(en)
*
|
2023-07-19 |
2025-01-23 |
Genethon |
Novel optimized utrophin micro-genes
|